Two deals this week show established corporations channeling capital into robotics not through arms-length licensing or acquisition but through embedded co-development structures designed to close the gap between lab capability and deployed product.
Why it matters
Smith & Nephew's five-year surgical robotics center at Imperial College London and NEC's venture investment in U.S. humanoid-robot startup Dexmate share a structural logic: both pair a large incumbent's distribution and domain expertise with a research partner's technical depth, and both explicitly target real-world deployment rather than pure research. ANALYSIS The pattern suggests that robotics capital is flowing toward arrangements where the investor retains operational proximity to the technology, a departure from the passive financial bets that characterized earlier waves of robotics funding.
Smith & Nephew and Imperial College London launched a five-year partnership focused on robotic surgery for musculoskeletal conditions2. The center marks the first time Smith & Nephew has founded a research center within a university, and Imperial's first industry center in medical technology. Rather than licensing or spinning out discoveries, Smith & Nephew engineers will work directly alongside university researchers to co-develop new solutions. Professor Ferdinando Rodriguez y Baena, who will lead the center, said it "establishes a third route to patients beyond licensing or spinout companies".
Separately, NEC's corporate venture capital fund, the NEC Orchestrating Future Fund, invested an undisclosed amount in Dexmate, a U.S. startup founded in 2024 that develops the Vega wheeled humanoid robot and an integrated physical AI development platform3,1. NEC said the investment is intended to support exploration of potential business collaboration, with a focus on the practical deployment of physical AI in real-world environments4.
The big picture
The Smith & Nephew center will sit within Imperial's Hamlyn Centre, part of the Institute of Global Health Innovation. Research topics include computer vision that reads and adapts to a patient's anatomy in real time and markerless registration and tracking, which removes the pins and rigid markers that current systems bolt to bone. The stated goal is making robotic surgery less invasive and available beyond specialist centres. At full capacity, the center will support a senior postdoctoral researcher and up to seven fully funded PhD studentships. Professor Mary Ryan, Imperial's Vice-Provost for Research and Enterprise, said Imperial will "work directly with Smith+Nephew to bring advanced innovations rapidly to the clinic".
Dexmate's Vega robot runs AI models onboard using an Nvidia Jetson Thor with 128 GB of memory and about 2,070 AI TFLOPS. Its 4.8 kWh battery provides about 20 hours of runtime or more than 16 hours at full AI compute load. The robot's three-section folding torso can reach from floor level to more than two meters high, and each arm can carry 15 lbs. Safety systems include brakes on major joints, real-time self-collision checking, a validation layer that blocks commands outside defined limits, and a software-accessible emergency stop. Dexmate uses hardware-synchronized sensors intended to produce aligned data for training AI models.
ANALYSIS Both deals are structured to keep the corporate partner inside the development loop from the start. Smith & Nephew is not writing a check and waiting for a license; it is embedding engineers in a university lab. NEC is not simply buying equity in a humanoid startup; it is framing the investment around joint exploration of deployment scenarios across multiple industries. The common thread is that incumbents with existing customer relationships and regulatory knowledge are positioning themselves as co-creators rather than late-stage acquirers.
The technical priorities also converge on a shared bottleneck: bridging perception and action in unstructured environments. Smith & Nephew's center targets computer vision that adapts to individual patient anatomy in real time. Dexmate's platform emphasizes hardware-synchronized sensor data for training physical AI models. Both are investing in the data-to-decision pipeline that determines whether a robot can operate reliably outside controlled settings.
Smith & Nephew, now in its 170th year, and NEC, a Japanese technology conglomerate, are not natural peers. ANALYSIS Yet their parallel moves illustrate how robotics investment is fragmenting by application domain while converging on a single deal structure: embedded, co-development partnerships that tie capital to operational access.
What's next
The Smith & Nephew-Imperial center's five-year timeline sets a concrete horizon for translating markerless tracking and real-time computer vision into clinical techniques. NEC and Dexmate plan to explore deployment of physical AI technologies across multiple industries, though neither company has specified target sectors or timelines. The center's PhD cohort, once fully staffed, will be an early indicator of whether the co-development model produces publishable and deployable results faster than traditional licensing arrangements.